Trial Profile
AK-R215 Pharmacokinetic Study Pharmacokinetic Characteristics of AK-R215 in Comparison to Each Component Coadministered in Healthy Adult Male or Menopausal Female Volunteers.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Bazedoxifene/colecalciferol (Primary) ; Bazedoxifene; Colecalciferol
- Indications Osteoporosis
- Focus Pharmacokinetics
- Sponsors Alvogen Korea
- 01 Nov 2017 New trial record